A genome-wide positioning systems network algorithm for in silico drug repurposing

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · see citing works

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

LIBSVM: A library for support vector machines

Chang, C.-C., & Lin, C.-J. (2011) · ACM Transactions on Intelligent Systems and Technology · doi:10.1145/1961189.1961199 · Cited by 40,918 · see citing works

Database resources of the National Center for Biotechnology Information: update

Wheeler, D. L. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkh073 · Cited by 10,691 · see citing works

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950 · see citing works

UniProt: the Universal Protein knowledgebase

Apweiler, R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkh131 · Cited by 7,535 · see citing works

Targeting HIF-1 for cancer therapy

Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · see citing works

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

Bindea, G., Mlecnik, B., Hackl, H., Charoentong, P., Tosolini, M., Kirilovsky, A., Fridman, W.-H., Pagès, F., Trajanoski, Z., & Galon, J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp101 · Cited by 6,280 · see citing works

Comprehensive molecular profiling of lung adenocarcinoma

The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732 · see citing works

The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257 · see citing works

Finishing the euchromatic sequence of the human genome

International Human Genome Sequencing Consortium (2004) · Nature · doi:10.1038/nature03001 · Cited by 4,971 · see citing works

ChEMBL: a large-scale bioactivity database for drug discovery

Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382 · see citing works

Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1111 · Cited by 4,051 · see citing works

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers

Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634 · see citing works

PhosphoSitePlus, 2014: mutations, PTMs and recalibrations

Hornbeck, P. V., Zhang, B., Murray, B., Kornhauser, J. M., Latham, V. M., & Skrzypek, E. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1267 · Cited by 3,243 · see citing works

A census of human cancer genes

Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184 · see citing works

Genetics of rheumatoid arthritis contributes to biology and drug discovery

the RACI consortium, Okada, Y., the GARNET consortium, Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., et al. (2014) · Nature · doi:10.1038/nature12873 · Cited by 2,310 · see citing works

BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities

Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl999 · Cited by 2,145 · see citing works

DrugBank 4.0: shedding new light on drug metabolism

Law, V., Knox, C., Djoumbou-Feunang, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,995 · see citing works

The MIntAct project—IntAct as a common curation platform for 11 molecular interaction databases

Orchard, S. E., Ammari, M. G., Aranda, B., Breuza, L., Briganti, L., Broackes-Carter, F. C., Campbell, N. H., Chavali, G. B., Chen, C. C. L., del‐Toro, N., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1115 · Cited by 1,835 · see citing works

Uncovering disease-disease relationships through the incomplete interactome

Menche, J., Sharma, A., Kitsak, M., Ghiassian, S. D., Vidal, M., Loscalzo, J., & Barabási, A.-L. (2015) · Science · doi:10.1126/science.1257601 · Cited by 1,546 · see citing works

Database resources of the National Center for Biotechnology Information

Coordinators, N. R. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1290 · Cited by 1,459 · see citing works

A Proteome-Scale Map of the Human Interactome Network

Rolland, T., Taşan, M., Charloteaux, B., Pevzner, S. J., Zhong, Q., Sahni, N., Yi, S. S., Lemmens, I. H., Fontanillo, C., Mosca, R., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.050 · Cited by 1,342 · see citing works

InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation

Breuer, K., Foroushani, A. B. K., Laird, M. R., Chen, C. C. L., Sribnaia, A., Lo, R., Winsor, G. L., Hancock, R. E. W., Brinkman, F. S. L., & Lynn, D. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1147 · Cited by 1,224 · see citing works

MINT, the molecular interaction database: 2012 update

Licata, L., Briganti, L., Peluso, D., Perfetto, L., Iannuccelli, M., Galeota, E., Sacco, F., Palma, A., Nardozza, A. P., Santonico, E., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr930 · Cited by 1,062 · see citing works

Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes

Leiserson, M. D. M., Vandin, F., Wu, H.-T., Dobson, J. R., Eldridge, J. V., Thomas, J. L., Papoutsaki, A., Kim, Y., Niu, B., McLellan, M. D., et al. (2014) · Nature Genetics · doi:10.1038/ng.3168 · Cited by 900 · see citing works

The BioGRID interaction database: 2015 update

Chatr‐aryamontri, A., Breitkreutz, B., Oughtred, R., Boucher, L., Heinicke, S., Chen, D., Stark, C., Breitkreutz, A., Kolas, N. K., O’Donnell, L., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1204 · Cited by 884 · see citing works

Identification of Genes Upregulated in ALK -Positive and EGFR/KRAS/ALK -Negative Lung Adenocarcinomas

Okayama, H., Kohno, T., Ishii, Y., Shimada, Y., Shiraishi, K., Iwakawa, R., Furuta, K., Tsuta, K., Shibata, T., Yamamoto, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1403 · Cited by 881 · see citing works

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

Pawson, A. J., Sharman, J. L., Benson, H. E., Faccenda, E., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., Southan, C., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1143 · Cited by 845 · see citing works

Vemurafenib: the first drug approved for BRAF-mutant cancer

Bollag, G. E., Tsai, J. Y., Zhang, J., Zhang, C., Ibrahim, P. N., Nolop, K. B., & Hirth, P. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3847 · Cited by 825 · see citing works

Network-based prediction of drug combinations

Cheng, F., Kovács, I. A., & Barabási, A.-Ĺ. (2019) · Nature Communications · doi:10.1038/s41467-019-09186-x · Cited by 812 · see citing works

Molecular Minimal Residual Disease in Acute Myeloid Leukemia

Jongen‐Lavrencic, M., Grob, T., Hanekamp, D., Kavelaars, F. G., Hinai, A. S. A. A., Zeilemaker, A., Erpelinck-Verschueren, C. A. J., Gradowska, P. L., Meijer, R. J., Cloos, J. J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716863 · Cited by 783 · see citing works

NRF2 regulates serine biosynthesis in non–small cell lung cancer

DeNicola, G. M., Chen, P.-H., Mullarky, E., Sudderth, J., Hu, Z., Wu, D., Tang, H., Xie, Y., Asara, J. M., Huffman, K. E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3421 · Cited by 747 · see citing works

Phospho.ELM: a database of phosphorylation sites--update 2011

Dinkel, H., Chica, C., Via, A., Gould, C., Jensen, L. J., Gibson, T. J., & Diella, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1104 · Cited by 736 · see citing works

Network-based stratification of tumor mutations

Hofree, M., Shen, J. P., Carter, H. K., Gross, A. M., & Ideker, T. (2013) · Nature Methods · doi:10.1038/nmeth.2651 · Cited by 726 · see citing works

Human protein reference database as a discovery resource for proteomics

Peri, S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkh070 · Cited by 606 · see citing works

Widespread macromolecular interaction perturbations in human genetic disorders

Sahni, N., Yi, S., Taipale, M., Fuxman Bass, J. I., Coulombe-Huntington, J., Yang, F., Peng, J., Weile, J., Karras, G. I., Wang, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.013 · Cited by 594 · see citing works

Network-based approach to prediction and population-based validation of in silico drug repurposing

Cheng, F., Desai, R. J., Handy, D. E., Wang, R., Schneeweiss, S., Barabási, A.-L., & Loscalzo, J. (2018) · Nature Communications · doi:10.1038/s41467-018-05116-5 · Cited by 552 · cited 7× · see citing works

Drug development in the era of precision medicine

Dugger, S. A., Platt, A., & Goldstein, D. B. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.226 · Cited by 493 · see citing works

Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery

Zhu, F., Shi, Z., Qin, C., Tao, L., Liu, X., Xu, F., Zhang, L., Song, Y., Liu, X., Zhang, J., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr797 · Cited by 479 · see citing works

SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents

Zhao, Y., Hu, Q., Cheng, F., Su, N., Wang, A., Zou, Y., Hu, H., Chen, X., Hai‐Meng, Z. H. O. U., Huang, X., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.009 · Cited by 434 · see citing works

A DIseAse MOdule Detection (DIAMOnD) Algorithm Derived from a Systematic Analysis of Connectivity Patterns of Disease Proteins in the Human Interactome

Ghiassian, S. D., Menche, J., & Barabási, A.-Ĺ. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004120 · Cited by 388 · see citing works

PINA v2.0: mining interactome modules

Cowley, M. J., Pinese, M., Kassahn, K. S., Waddell, N., Pearson, J. V., Grimmond, S. M., Biankin, A. V., Hautaniemi, S., & Wu, J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr967 · Cited by 351 · see citing works

HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactionsPreprint

Bovolenta, L. A., Acencio, M. L., & Lemke, N. (2012) · Nature Precedings · doi:10.1186/1471-2164-13-405 · Cited by 267 · see citing works

Precision medicine in cardiology

Antman, E. M., & Loscalzo, J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.101 · Cited by 252 · see citing works

Signalling to eIF4E in cancer

Siddiqui, N., & Sonenberg, N. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150126 · Cited by 220 · see citing works

SignaLink 2 – a signaling pathway resource with multi-layered regulatory networks

Fazekas, D., Koltai, M., Türei, D., Módos, D., Pálfy, M., Dúl, Z., Zsákai, L., Szalay-Bekő, M., Lenti, K., Farkas, I. J., et al. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-7 · Cited by 198 · see citing works

dbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modifications

Lu, C. T., Huang, K.-Y., Su, M.-G., Lee, T.-Y., Bretaña, N. A., Chang, W., Chen, Y., Chen, Y., & Huang, H.-D. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1229 · Cited by 193 · see citing works

Construction of human activity‐based phosphorylation networks

Newman, R. H., Hu, J., Rho, H., Xie, Z., Woodard, C. L., Neiswinger, J., Cooper, C. L., Shirley, M. D., Clark, H. M., Hu, S., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.12 · Cited by 158 · see citing works

Src-Family Kinases Are Activated in Non-Small Cell Lung Cancer and Promote the Survival of Epidermal Growth Factor Receptor-Dependent Cell Lines

Zhang, J., Kalyankrishna, S., Wislez, M., Thilaganathan, N., Saigal, B., Wei, W., Ma, L., Wistuba, I. I., Johnson, F. M., & Kurie, J. M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060706 · Cited by 154 · see citing works

Interactome INSIDER: a structural interactome browser for genomic studies

Meyer, M. J., Beltrán, J. F., Liang, S., Fragoza, R., Rumack, A., Liang, J. H., Wei, X., & Yu, H. (2018) · Nature Methods · doi:10.1038/nmeth.4540 · Cited by 152 · see citing works

INstruct: a database of high-quality 3D structurally resolved protein interactome networks

Meyer, M. J., Das, J., Wang, X., & Yu, H. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt181 · Cited by 144 · see citing works

Preferential binding of HIF-1 to transcriptionally active loci determines cell-type specific response to hypoxia

Xia, X., & Kung, A. L. (2009) · Genome biology · doi:10.1186/gb-2009-10-10-r113 · Cited by 132 · see citing works

PhosphoNetworks: a database for human phosphorylation networks

Hu, J., Rho, H.-S., Newman, R. H., Zhang, J., Zhu, H., & Qian, J. X. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt627 · Cited by 115 · see citing works

The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge

Hernandez‐Boussard, T., Whirl‐Carrillo, M., Hebert, J. M., Gong, L., Owen, R., Gong, M., Gor, W., Liu, F., Truong, C., Whaley, R. M., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1009 · Cited by 113 · see citing works

Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy

Cheng, F., Jia, P., Wang, Q., & Zhao, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.1984 · Cited by 105 · see citing works

Repurposing sertraline sensitizes non–small cell lung cancer cells to erlotinib by inducing autophagy

Jiang, X., Lü, W., Shen, X., Wang, Q., Lv, J., Liu, M., Cheng, F., Zhao, Z., & Pang, X. (2018) · JCI Insight · doi:10.1172/jci.insight.98921 · Cited by 90 · see citing works

Studying Tumorigenesis through Network Evolution and Somatic Mutational Perturbations in the Cancer Interactome

Cheng, F., Jia, P., Wang, Q., Lin, C.-C., Li, W., & Zhao, Z. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu167 · Cited by 88 · see citing works

Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma

Lim, H. Y., Merle, P., Weiss, K. H., Yau, T. C. C., Ross, P. J., Mazzaferro, V., Blanc, J., Ma, Y. T., Yen, C. J., Kocsis, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3588 · Cited by 83 · see citing works

Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis

Cheng, F., Murray, J. L., Zhao, J., Sheng, J., Zhao, Z., & Rubin, D. H. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005074 · Cited by 58 · see citing works

A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes

Cheng, F., Zhao, J., Fooksa, M., & Zhao, Z. (2016) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocw007 · Cited by 55 · see citing works

Network-Based Disease Module Discovery by a Novel Seed Connector Algorithm with Pathobiological Implications

Wang, R., & Loscalzo, J. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.016 · Cited by 55 · see citing works

Ouabain Suppresses the Migratory Behavior of Lung Cancer Cells

Pongrakhananon, V., Chunhacha, P., & Chanvorachote, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068623 · Cited by 47 · see citing works

Inhibition of cell migration by ouabain in the A549 human lung cancer cell line

Liu, N., Li, Y., Su, S., Wang, N., Wang, H., & Li, J. (2013) · Oncology Letters · doi:10.3892/ol.2013.1406 · Cited by 44 · see citing works

Nine paths to PCSK9 inhibition

Mullard, A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.83 · Cited by 43 · see citing works

LEO1 Is Regulated by PRL-3 and Mediates Its Oncogenic Properties in Acute Myelogenous Leukemia

Chong, P. S. Y., Zhou, J., Cheong, L.-L., Liu, S.-C., Qian, J., Guo, T., Sze, S. K., Zeng, Q., & Chng, W. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2321 · Cited by 32 · see citing works

A reference map of the human protein interactomePreprint

Luck, K., Kim, D., Lambourne, L., Spirohn, K., Begg, B. E., Bian, W., Brignall, R., Cafarelli, T. M., Campos-Laborie, F. J., Charloteaux, B., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/605451 · Cited by 27 · see citing works

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,588 · see citing works

Overcoming cancer therapeutic bottleneck by drug repurposing

Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 521 · see citing works

Artificial intelligence in cancer target identification and drug discovery

You, Y., Lai, X., Pan, Y. F., Zheng, H., Vera, J., Liu, S., Deng, S., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00994-0 · Cited by 476 · see citing works

COVID-19 and Cardiovascular Disease

Chung, M. K., Zidar, D. A., Bristow, M. R., Cameron, S. J., Chan, T. A.-T., Harding, C. V., Kwon, D. H., Singh, T. K., Tilton, J. C., Tsai, E. J., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.317997 · Cited by 371 · see citing works

Target identification among known drugs by deep learning from heterogeneous networks

Zeng, X., Zhu, S., Lu, W., Liu, Z., Huang, J., Zhou, Y., Fang, J., Huang, Y., Guo, H., Li, L., et al. (2020) · Chemical Science · doi:10.1039/c9sc04336e · Cited by 357 · see citing works

Graph representation learning in biomedicine and healthcare

Li, M. M., Huang, K., & Zitnik, M. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00942-x · Cited by 294 · see citing works

Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning

Zeng, X., Song, X. H., Ma, T., Pan, X., Zhou, Y., Hou, Y., Zhang, Z., Li, K., Karypis, G., & Cheng, F. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00316 · Cited by 258 · see citing works

Comprehensive characterization of protein–protein interactions perturbed by disease mutations

Cheng, F., Zhao, J., Wang, Y., Lü, W., Liu, Z., Zhou, Y., Martin, W. R., Wang, R., Huang, J. Y., Hao, T., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00774-y · Cited by 216 · see citing works

Computational network biology: Data, models, and applications

Liu, C., Ma, Y., Zhao, J., Nussinov, R., Zhang, Y., Cheng, F., & Zhang, Z. (2019) · Physics Reports · doi:10.1016/j.physrep.2019.12.004 · Cited by 226 · see citing works

Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients

Kong, J., Lee, H., Kim, D., Han, S. K., Ha, D., Shin, K., & Kim, S. (2020) · Nature Communications · doi:10.1038/s41467-020-19313-8 · Cited by 220 · see citing works

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease

Fang, J., Zhang, P., Zhou, Y., Chiang, C.-W., Tan, J., Hou, Y., Stauffer, S., Li, L., Pieper, A. A., Cummings, J., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00138-z · Cited by 206 · see citing works

A comprehensive SARS-CoV-2–human protein–protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets

Zhou, Y., Liu, Y., Gupta, S., Paramo, M. I., Hou, Y., Mao, C., Luo, Y., Judd, J., Wierbowski, S. D., Bertolotti, M., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01474-0 · Cited by 203 · see citing works

Deep learning for drug repurposing: Methods, databases, and applications

Pan, X., Lin, X., Cao, D., Zeng, X., Yu, P. S., He, L., Nussinov, R., & Cheng, F. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1597 · Cited by 193 · see citing works

A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19

Zhou, Y., Hou, Y., Shen, J., Mehra, R., Kallianpur, A., Culver, D. A., Gack, M. U., Farha, S., Zein, J., Comhair, S., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000970 · Cited by 180 · see citing works

Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment

Zhou, Y., Xu, J., Hou, Y., Leverenz, J. B., Kallianpur, A. R., Mehra, R., Liu, Y., Yu, H., Pieper, A. A., Jehi, L. E., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00850-3 · Cited by 160 · see citing works

Network-based prediction of drug–target interactions using an arbitrary-order proximity embedded deep forest

Zeng, X., Zhu, S., Hou, Y., Zhang, P., Li, L., Li, J., Huang, L. F., Lewis, S. J., Nussinov, R., & Cheng, F. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa010 · Cited by 143 · see citing works

Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease

Fang, J., Zhang, P., Wang, Q., Chiang, C.-W., Zhou, Y., Hou, Y., Xu, J., Chen, R., Zhang, B., Lewis, S. J., et al. (2022) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-021-00951-z · Cited by 140 · see citing works

Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer’s disease

Xu, J., Mao, C., Hou, Y., Luo, Y., Binder, J. L., Zhou, Y., Bekris, L. M., Shin, J., Hu, M., Wang, F., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111717 · Cited by 115 · see citing works

Network medicine framework for identifying drug-repurposing opportunities for COVID-19

Morselli Gysi, D., do Valle, Í., Zitnik, M., Ameli, A., Gan, X., Varol, O., Ghiassian, S. D., Patten, J. J., Davey, R. A., Loscalzo, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025581118 · Cited by 107 · see citing works

Graph embedding and Gaussian mixture variational autoencoder network for end-to-end analysis of single-cell RNA sequencing data

Xu, J., Xu, J., Meng, Y., Lu, C., Cai, L., Zeng, X., Nussinov, R., & Cheng, F. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100382 · Cited by 102 · see citing works

Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing

Fang, J., Pieper, A. A., Nussinov, R., Lee, G., Bekris, L. M., Leverenz, J. B., Cummings, J. L., & Cheng, F. (2020) · Medicinal Research Reviews · doi:10.1002/med.21709 · Cited by 93 · see citing works

AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer’s drug discovery

Zhou, Y., Fang, J., Bekris, L. M., Kim, Y. H., Pieper, A. A., Leverenz, J. B., Cummings, J. L., & Cheng, F. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00760-w · Cited by 86 · see citing works

Advances of Artificial Intelligence in Anti-Cancer Drug Design: A Review of the Past Decade

Wang, L., Song, Y., Wang, H., Zhang, X., Wang, M., He, J., Li, S., Zhang, L., Li, K., & Cao, L. (2023) · Pharmaceuticals · doi:10.3390/ph16020253 · Cited by 86 · see citing works

Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's diseasePreprint

Xu, J., Zhang, P., Huang, Y., Zhou, Y., Hou, Y., Bekris, L. M., Lathia, J. D., Chiang, C., Li, L., Pieper, A. A., et al. (2021) · Genome Research · doi:10.1101/gr.272484.120 · Cited by 82 · see citing works

Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions

Fu, L., Jin, W., Zhang, J., Zhu, L., Lu, J., Zhen, Y., Zhang, L., Ouyang, L., Liu, B., & Yu, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.006 · Cited by 83 · see citing works

Drug targets for COVID-19 therapeutics: Ongoing global efforts

Saxena, A. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00067-w · Cited by 83 · see citing works

From genetic associations to genes: methods, applications, and challenges

Qi, T., Song, L., Guo, Y., Chen, C., & Yang, J. (2024) · Trends in Genetics · doi:10.1016/j.tig.2024.04.008 · Cited by 84 · see citing works

Deep learning of pharmacogenomics resources: moving towards precision oncology

Chiu, Y., Chen, H.-I. H., Gorthi, A., Mostavi, M., Zheng, S., Huang, Y., & Chen, Y. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz144 · Cited by 77 · see citing works

Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach

Moolamalla, S. T. R., Balasubramanian, R., Chauhan, R., Priyakumar, U. D., & Vinod, P. K. U. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105114 · Cited by 73 · see citing works

Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients: a meta-analysis of randomized clinical trials

Benedetti, R., Benincasa, G., Glass, K., Chianese, U., Vietri, M. T., Congi, R., Altucci, L., & Claudio Napoli, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106039 · Cited by 75 · see citing works

Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches

Ahmed, F., Kang, I. S., Kim, K. H., Asif, A., Rahim, C. S. A., Samantasinghar, A., Memon, F. H., & Choi, K. H. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28693 · Cited by 75 · see citing works

Drug repurposing for Alzheimer’s disease and other neurodegenerative disorders

Cummings, J. L., Zhou, Y., Stone, A. V., Cammann, D., Tonegawa‐Kuji, R., Cacho, J. R. F., & Cheng, F. (2025) · Nature Communications · doi:10.1038/s41467-025-56690-4 · Cited by 61 · see citing works

Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug–drug links based on graph neural network

Cui, C., Ding, X., Wang, D., Chen, L., Xiao, F., Xu, T., Zheng, M., Luo, X., Jiang, H., & Chen, K. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab191 · Cited by 56 · see citing works

Community Detection in Protein-Protein Interaction Networks and Applications

Manipur, I., Giordano, M., Piccirillo, M., Parashuraman, S., & Maddalena, L. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3138142 · Cited by 56 · see citing works

Molecular interaction networks and drug development: Novel approach to drug target identification and drug repositioning

Loscalzo, J. (2022) · The FASEB Journal · doi:10.1096/fj.202201683r · Cited by 55 · see citing works

New insight into the role of isorhamnetin as a regulator of insulin signaling pathway in type 2 diabetes mellitus rat model: Molecular and computational approach

Matboli, M., Saad, M., Hasanin, A. H., Saleh, L. A., Baher, W., Bekhet, M. M., & Eissa, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111176 · Cited by 56 · see citing works

Fluid-based assays and precision medicine of cardiovascular diseases: the ‘hope’ for Pandora’s box?

Benincasa, G., Mansueto, G., & Claudio Napoli, A. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2019-206178 · Cited by 55 · see citing works

A new precision medicine initiative at the dawn of exascale computing

Nussinov, R., Jang, H., Nir, G., Tsai, C., & Cheng, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00420-3 · Cited by 54 · see citing works

Transcriptomics-Based Network Medicine Discovery and Population-Based Validation Identifies Metformin as a Candidate Drug for Atrial Fibrillation

Lal, J. C., Mao, C., Zhou, Y., Gore-Panter, S. R., Rennison, J. H., Lovano, B. S., Castel, L., Shin, J., Gillinov, A. M., Smith, J. D., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100749 · Cited by 47 · see citing works

Repurposed drug candidates for antituberculosis therapy

An, Q., Li, C., Chen, Y., Deng, Y., Yang, T., & Luo, Y. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112175 · Cited by 50 · see citing works

DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer’s disease

Li, V. O. K., Yang, H., Kaistha, T., Zhang, Q., Downey, J., Gozes, I., & Lam, J. C. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-85947-7 · Cited by 57 · see citing works

Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data

Su, C., Hou, Y., Xu, J., Xu, Z., Zhou, M., Ke, A., Li, H., Xu, J., Brendel, M., Maasch, J. R. M. A., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01175-9 · Cited by 55 · see citing works

Comparison of machine learning and deep learning techniques in promoter prediction across diverse species

Bhandari, N., Khare, S., Walambe, R. A., & Kotecha, K. V. (2021) · PeerJ Computer Science · doi:10.7717/peerj-cs.365 · Cited by 47 · see citing works

Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes

Liu, C., Zhao, J., Lü, W., Dai, Y., Hockings, J. K., Zhou, Y., Nussinov, R., Eng, C., & Cheng, F. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007701 · Cited by 46 · see citing works

Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis

Adhami, M., Sadeghı, B., Rezapour, A., Haghdoost, A. A., & MotieGhader, H. (2021) · BMC Biotechnology · doi:10.1186/s12896-021-00680-z · Cited by 44 · see citing works

Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases

Kumar, M. A., Baba, S. K., Khan, I. R., Khan, M. S., Husain, F. M., Ahmad, S., Haris, M., Singh, M., Akil, A. A., Macha, M. A., et al. (2025) · MedComm · doi:10.1002/mco2.70120 · Cited by 49 · see citing works

Old drugs, new uses: Drug repurposing in hematological malignancies

Kale, V. P., Habib, H., Chitren, R. J., Patel, M., Pramanik, K. C., Jonnalagadda, S. C., Challagundla, K. B., & Pandey, M. K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.005 · Cited by 44 · see citing works

Evaluating the performance of drug-repurposing technologies

Schuler, J., Falls, Z., Mangione, W., Hudson, M. L., Bruggemann, L., & Samudrala, R. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.08.002 · Cited by 44 · see citing works

Drug Repurposing for Cancer Therapy in the Era of Precision Medicine

To, K. K. W., & Cho, W. C. S. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220214104530 · Cited by 42 · see citing works

In silico identification of natural products from Traditional Chinese Medicine for cancer immunotherapy

Cai, C., Wu, Q., Hong, H., He, L., Liu, Z., Gu, Y., Zhang, S., Wang, Q., Fan, X., & Fang, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-82857-2 · Cited by 41 · see citing works

GADRP: graph convolutional networks and autoencoders for cancer drug response prediction

Wang, H., Dai, C., Wen, Y., Wang, X., Liu, W., He, S., Bo, X., & Peng, S. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac501 · Cited by 40 · see citing works

Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease

Ren, Y., Pieper, A. A., & Cheng, F. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00553 · Cited by 42 · see citing works

Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks

Zhang, Y., Lei, X., Pan, Y. F., & Wu, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.872785 · Cited by 38 · see citing works

Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing

Malla, R. R., Sathiyapriya, V., Makena, S., Kapoor, S. S., Verma, D., Raju, A. A., Dunna, M., & Muniraj, N. (2024) · Cancers · doi:10.3390/cancers16081463 · Cited by 42 · see citing works

Network approaches for modeling the effect of drugs and diseases

Rintala, T., Ghosh, A., & Fortino, V. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac229 · Cited by 36 · see citing works

Computational Approaches to Drug Repurposing: Methods, Challenges, and Opportunities

Cousins, H. C., Nayar, G., & Altman, R. B. (2024) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-110123-025333 · Cited by 40 · see citing works

A network-based approach to uncover microRNA-mediated disease comorbidities and potential pathobiological implications

Jin, S., Zeng, X., Fang, J., Lin, J., Chan, S. Y., ERZURUM, S. C., & Cheng, F. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0115-2 · Cited by 35 · see citing works

Cardiac risk stratification in cancer patients: A longitudinal patient–patient network analysis

Hou, Y., Zhou, Y., Hussain, M., Budd, G. T., Tang, W. H. W., Abraham, J., Xu, B., Shah, C., Moudgil, R., Popović, Z., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003736 · Cited by 36 · see citing works

A review of COVID-19 biomarkers and drug targets: resources and tools

Caruso, F. P., Scala, G., Cerulo, L., & Ceccarelli, M. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa328 · Cited by 33 · see citing works

Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop

Leopold, J. A., Kawut, S. M., Aldred, M. A., Archer, S. L., Benza, R. L., Bristow, M. R., Brittain, E. L., Chesler, N. C., DeMan, F. S., ERZURUM, S. C., et al. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007975 · Cited by 32 · see citing works

Promising Strategies for Preserving Adult Endothelium Health and Reversing Its Dysfunction: From Liquid Biopsy to New Omics Technologies and Noninvasive Circulating Biomarkers

Balistreri, C. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147548 · Cited by 32 · see citing works

Using informative features in machine learning based method for COVID-19 drug repurposing

Aghdam, R., Habibi, M., & Taheri, G. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00553-9 · Cited by 31 · see citing works

Unlocking biological insights from differentially expressed genes: Concepts, methods, and future perspectives

Yin, H., Duo, H., Li, S., Qin, D., Xie, L., Xiao, Y., Sun, J., Tao, J., Zhang, X., Li, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.12.004 · Cited by 31 · see citing works

Drug repurposing in silico screening platforms

Mullins, J. G. L. (2022) · Biochemical Society Transactions · doi:10.1042/bst20200967 · Cited by 29 · see citing works

Centrality of drug targets in protein networks

Follis, A. V. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04342-x · Cited by 28 · see citing works

COVID-19 treatment: Combining anti-inflammatory and antiviral therapeutics using a network-based approach

Cheng, F., Rao, S., & Mehra, R. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.ccc037 · Cited by 26 · see citing works

Systems pharmacology approach uncovers the therapeutic mechanism of medicarpin against scopolamine-induced memory loss

Li, D., Cai, C., Liao, Y., Wu, Q., Ke, H., Guo, P., Wang, Q., Ding, B., Fang, J., & Fang, S. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153662 · Cited by 28 · see citing works

Network module‐based drug repositioning for pulmonary arterial hypertension

Wang, R., & Loscalzo, J. (2021) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12670 · Cited by 25 · see citing works

A network-based deep learning methodology for stratification of tumor mutations

Liu, C., Han, Z. Y., Zhang, Z., Nussinov, R., & Cheng, F. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa1099 · Cited by 23 · see citing works

Cancer driver drug interaction explorer

Hartung, M., Anastasi, E., Mamdouh, Z. M., Nogales, C., Schmidt, H. H. H. W., Baumbach, J., Zolotareva, O. I., & List, M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac384 · Cited by 24 · see citing works

Network-based drug repurposing identifies small molecule drugs as immune checkpoint inhibitors for endometrial cancer

Ahmed, F., Samantasinghar, A., Ali, W., & Choi, K. H. (2024) · Molecular Diversity · doi:10.1007/s11030-023-10784-7 · Cited by 23 · see citing works

Construction, comparison and evolution of networks in life sciences and other disciplines

Gysi, D. M., & Nowick, K. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2019.0610 · Cited by 25 · see citing works

Network determinants of cardiovascular calcification and repositioned drug treatments

Song, J.-S., Wang, R., Leopold, J. A., & Loscalzo, J. (2020) · The FASEB Journal · doi:10.1096/fj.202001062r · Cited by 21 · see citing works

Comprehensive assessment of side effects in COVID-19 drug pipeline from a network perspective

Wu, Q., Fan, X., Hong, H., Gu, Y., Liu, Z., Fang, S., Wang, Q., Cai, C., & Fang, J. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111767 · Cited by 21 · see citing works

A hierarchical attention network integrating multi-scale relationship for drug response prediction

Wang, X., Wen, Y., Zhang, Y., Dai, C., Yang, Y., Bo, X., He, S., & Peng, S. (2024) · Information Fusion · doi:10.1016/j.inffus.2024.102485 · Cited by 21 · see citing works

Pharmacogenomics for immunotherapy and immune-related cardiotoxicity

Lal, J. C., Eng, C., & Cheng, F. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa137 · Cited by 20 · see citing works

Network Medicine: A Potential Approach for Virtual Drug Screening

Ma, M., Huang, M. J., He, Y., Fang, J., Li, J., Li, X., Liu, M., Zhou, M., Cui, G., & Fan, Q. (2024) · Pharmaceuticals · doi:10.3390/ph17070899 · Cited by 20 · see citing works

NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification

Oldham, W. M., Hemnes, A. R., Aldred, M. A., Barnard, J., Brittain, E. L., Chan, S. Y., Cheng, F., Cho, M. H., Desai, A. A., Garcia, J. G. N., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.056 · Cited by 20 · see citing works

The Impact of Artificial Intelligence on Cancer Diagnosis and Treatment: A Review

Najafi, N. N., Hajihassani, H., & Irani, M. A. (2025) · Cancer Informatics · doi:10.1177/11769351251371273 · Cited by 18 · see citing works

Lung adenocarcinoma-related target gene prediction and drug repositioning

Huang, R., Siriwanna, D., Cho, W. C. S., Wan, T. K., Du, Y. R., Bennett, A. N., He, Q., Liu, J., Huang, X. T., & Chan, K. H. K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.936758 · Cited by 18 · see citing works

A compact review of progress and prospects of deep learning in drug discovery

Li, H., Zou, L., Kowah, J. A. H., He, D., Liu, Z., Ding, X., Wen, H., Wang, L., Yuan, M., & Liu, X. (2023) · Journal of Molecular Modeling · doi:10.1007/s00894-023-05492-w · Cited by 18 · see citing works

Phosphorylation of PLCγ1 by EphA2 Receptor Tyrosine Kinase Promotes Tumor Growth in Lung Cancer

Song, W., Kim, L. C., Han, W., Hou, Y., Edwards, D. N., Wang, S., Blackwell, T. S., Cheng, F., Brantley‐Sieders, D. M., & Chen, J. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0075 · Cited by 18 · see citing works

Identifying miRNAs in multiple sclerosis gray matter lesions that correlate with atrophy measures

Tripathi, A. K., Pandit, I., Perles, A., Zhou, Y., Cheng, F., & Dutta, R. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51365 · Cited by 18 · see citing works

In silico approaches for drug repurposing in oncology: a scoping review

Cavalcante, B. R. R., Freitas, R. D., da Rocha, L. D. O. S., dos Santos, R. D. S. B., Souza, B. S. D. F., Ramos, P. I. P., Rocha, G. V., & Rocha, C. A. G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1400029 · Cited by 17 · see citing works

Enhancing Cancer Driver Gene Prediction by Protein-Protein Interaction Network

Liu, C., Dai, Y., Yu, K., & Zhang, Z. (2021) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2021.3063532 · Cited by 16 · see citing works

Pathway-Based Drug Repurposing with DPNetinfer: A Method to Predict Drug–Pathway Associations via Network-Based Approaches

Wang, J., Wu, Z., Peng, Y., Li, W., Liu, G., & Tang, Y. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00009 · Cited by 17 · see citing works

Effect of FKBP12-Derived Intracellular Peptides on Rapamycin-Induced FKBP–FRB Interaction and Autophagy

Parada, C. A., de Oliveira, I. P., Gewehr, M. C. F., Machado‐Neto, J. A., Lima, K., Eichler, R. A. D. S., Lopes, L. R., Bechara, L. R. G., Ferreira, J. C. B., Festuccia, W. T., et al. (2022) · Cells · doi:10.3390/cells11030385 · Cited by 17 · see citing works

Harnessing Artificial Intelligence in Pediatric Oncology Diagnosis and Treatment: A Review

Hassan, M., Shahzadi, S., & Kloczkowski, A. (2025) · Cancers · doi:10.3390/cancers17111828 · Cited by 19 · see citing works

Network-based identification and mechanism exploration of active ingredients against Alzheimer’s disease via targeting endoplasmic reticulum stress from traditional chinese medicine

Dai, Z., Tian, H., Wei, J., Wang, X., Cai, C., Gu, Y., Hu, Y., Wang, W., Wu, Q., & Fang, J. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.12.017 · Cited by 16 · see citing works

Unravelling the mosaic: Epigenetic diversity in glioblastoma

Lucchini, S., Constantinou, M., & Marino, S. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13706 · Cited by 17 · see citing works

Repurposing of medications for pulmonary arterial hypertension

Toshner, M. R., Spiekerkoetter, E. F., Bogaard, H. J., Hansmann, G., Nikkho, S. M., & Prins, K. W. (2020) · Pulmonary Circulation · doi:10.1177/2045894020941494 · Cited by 16 · see citing works

Essentiality and Transcriptome-Enriched Pathway Scores Predict Drug-Combination Synergy

Li, J., Huo, Y., Wu, X., Liu, E., Zeng, Z., Tian, Z., Fan, K., Stover, D. G., Cheng, L., & Li, L. (2020) · Biology · doi:10.3390/biology9090278 · Cited by 16 · see citing works

Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis

Rajput, A., Thakur, A., Rastogi, A., Choudhury, S., & Kumar, M. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104677 · Cited by 16 · see citing works

Evolution of precision oncology‐guided treatment paradigms

DasGupta, R., Yap, A., Yong, E. Y., & Chia, S. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1585 · Cited by 17 · see citing works

SOAR elucidates disease mechanisms and empowers drug discovery through spatial transcriptomicsPreprint

Li, Y., Dennis, S., Hutch, M. R., Ding, Y., Zhou, Y., Li, Y., Pillai, M., Ghotbaldini, S., Garcia, M., Broad, M. S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.17.488596 · Cited by 16 · see citing works

Network-Based Identification and Experimental Validation of Drug Candidates Toward SARS-CoV-2 via Targeting Virus–Host Interactome

Fang, J., Wu, Q., Ye, F., Cai, C., Xu, L., Gu, Y., Wang, Q., Liu, A., Tan, W., & Du, G. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.728960 · Cited by 14 · see citing works

A signaling pathway-driven bioinformatics pipeline for predicting therapeutics against emerging infectious diseases

Scott, T. M., Jensen, S., & Pickett, B. E. (2021) · F1000Research · doi:10.12688/f1000research.52412.1 · Cited by 12 · see citing works

Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example

Imami, A. S., McCullumsmith, R. E., & O'Donovan, S. M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01724-w · Cited by 15 · see citing works

Artificial Intelligence and Network Medicine: Path to Precision Medicine

Altucci, L., Badimón, L., Balligand, J., Baumbach, J., Catapano, A. L., Cheng, F., DeMeo, D. L., Gupta, R. M., Hacker, M., Liu, Y., et al. (2025) · NEJM AI · doi:10.1056/aira2401229 · Cited by 16 · see citing works

NMSDR: Drug repurposing approach based on transcriptome data and network module similarity

Ünsal, Ü., Cüvitoğlu, A., Turhan, K., & Işık, Z. (2022) · Molecular Informatics · doi:10.1002/minf.202200077 · Cited by 1 · see citing works

NeDRex - an integrative and interactive network medicine platform for drug repurposing

Sadegh, S., Skelton, J., Anastasi, E., Blumenthal, D. B., Maier, A., Galindez, G., Nogales, C., Casas, A. I., Schmidt, H. H. H. W., Wipat, A., et al. (2022) · doi:10.14293/s2199-1006.1.sor-.pppy90r8.v1 · Cited by 3 · see citing works

RepurNet: A network medicine framework for systematic drug repurposing and disease vulnerability discovery

Pentaparthi, S. R., Zou, R., Chhibbar, P., Shrawat, A., Belchior, M. B., Peng, W., Geldenhuys, W. J., Khan, M. A. U., Huang, J. H., Bass, J. I. F., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115896

Network medicine for disease module identification and drug repurposing with the NeDRex platform

Sadegh, S., Skelton, J., Anastasi, E., Bernett, J., Blumenthal, D. B., Galindez, G., Salgado-Albarrán, M., Lazareva, O., Flanagan, K., Cockell, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27138-2 · Cited by 151 · see citing works

Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach

Emig, D., Ivliev, A. E., Pustovalova, O., Lancashire, L., Bureeva, S. V., Nikolsky, Y., & Bessarabova, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060618 · Cited by 242 · see citing works